Publications

Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection.

Gu Q. et al, (2024), J Infect

Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23

Cane J. et al, (2023)

Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022.

Harrison RE. et al, (2023), Emerging infectious diseases, 29, 2024 - 2031

Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey.

Lythgoe KA. et al, (2023), Proceedings. Biological sciences, 290

When should factorial designs be used for late-phase randomised controlled trials?

White IR. et al, (2023), Clinical trials (London, England)

A workflow for the detection of antibiotic residues, measurement of water chemistry and preservation of hospital sink drain samples for metagenomic sequencing

Rodger G. et al, (2023)

[A global core outcome measurement set for snakebite clinical trials].

Abouyannis M. et al, (2023), Medecine tropicale et sante internationale, 3

Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population

Wei J. et al, (2023)

Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS).

Russell NJ. et al, (2023), PLoS medicine, 20

Challenges in the Implementation of the NeoOBS Study, a Global Pragmatic Observational Cohort Study, to Investigate the Aetiology and Management of Neonatal Sepsis in the Hospital Setting

Riddell A. et al, (2023), Antibiotics, 12, 923 - 923

Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failure.

Flower B. et al, (2023), Clinical liver disease, 21, 138 - 142

Risk of new-onset Long Covid following reinfection with SARS-CoV-2: community-based cohort study

Bosworth ML. et al, (2023)

Employment outcomes of people with Long Covid symptoms: community-based cohort study

Ayoubkhani D. et al, (2023)

Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification

Pouwels KB. et al, (2023)

Enterobacterales plasmid sharing amongst human bloodstream infections, livestock, wastewater, and waterway niches in Oxfordshire, UK.

Matlock W. et al, (2023), eLife, 12

Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial

Llewelyn MJ. et al, (2023), The Lancet Infectious Diseases, 23, 207 - 221

Impact of sub-optimal HIV viral control on activated T-cells: an earnest sub study.

Arrigoni FIF. et al, (2023), AIDS

Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trial

Olupot-Olupot P. et al, (2023)

Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for Hepatitis C: a single arm mechanistic pilot study

Flower B. et al, (2023), eLife, 12

Defining normal inflammatory marker and vital sign responses to suspected bloodstream infection in adults with positive and negative blood cultures

Gu Q. et al, (2023)

Exploring the extent of uncatalogued genetic variation in antimicrobial resistance gene families inEscherichia coli

Lipworth S. et al, (2023)

Increasing second-line antiretroviral therapy options for children with HIV in Africa: week-96 efficacy and safety results of the CHAPAS-4 randomised trial

Musiime V. et al, (2023), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 26

Microbial diversity and antimicrobial resistance in faecal samples from acute medical patients assessed through metagenomic sequencing.

Yokoyama M. et al, (2023), PLoS One, 18

Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.

Eleftheriou D. et al, (2023), Trials, 24

Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trial

Olupot-Olupot P. et al, (2023)

SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort

Dietz E. et al, (2023)

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)

Maitland K. et al, (2023)

Health record hiccups—5,526 real-world time series with change points labelled by crowdsourced visual inspection

Quan TP. et al, (2022), GigaScience, 12

Correlates of protection against SARS-CoV-2 Omicron variant and anti-spike antibody responses after a third/booster vaccination or breakthrough infection in the UK general population

Wei J. et al, (2022)

Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing ofM. tuberculosis

(2022), European Respiratory Journal, 60, 2200239 - 2200239

Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar

Pritchard E. et al, (2022)

Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study

Ayoubkhani D. et al, (2022), Open Forum Infectious Diseases

Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for Hepatitis C: a single arm mechanistic pilot study

Flower B. et al, (2022)

Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms

(2022), PLOS Biology, 20, e3001755 - e3001755

Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.

Ward IL. et al, (2022), BMJ (Clinical research ed.), 378

A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.

The CRyPTIC Consortium None., (2022), PLoS biology, 20

Mycobacterium tuberculosis transmission in Birmingham, UK, 2009–19: An observational study

Walker TM. et al, (2022), The Lancet Regional Health - Europe, 17, 100361 - 100361

Penicillin Binding Protein Substitutions Co-occur with Fluoroquinolone Resistance in ‘Epidemic’ Lineages of Multi Drug-Resistant Clostridioides difficile

Dingle KE. et al, (2022)

Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study

Ayoubkhani D. et al, (2022), BMJ, e069676 - e069676

Evaluation of metagenomic, 16S rRNA gene and ultra-plexed PCR-based sequencing approaches for profiling antimicrobial resistance gene and bacterial taxonomic composition of polymicrobial samples

Chau KK. et al, (2022)

An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status

Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219

COVID ‐19 vaccines and risks of hematological abnormalities: Nested case–control and self‐controlled case series study

Sing C. et al, (2022), American Journal of Hematology, 97, 470 - 480

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

Walker TM. et al, (2022), The Lancet Microbe, 3, e265 - e273

Assessment of a vancomycin dosing guideline and identification of predictive factors associated with dose and drug trough levels

Gu Q. et al, (2022)

Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2)

Ward IL. et al, (2022)

Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants

Eyre DW. et al, (2022), New England Journal of Medicine, 386, 744 - 756

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

Wei J. et al, (2022), Nature Medicine

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission

Lee LYW. et al, (2022), Clinical Infectious Diseases, 74, 407 - 415

Mortality risks associated with empirical antibiotic activity in E. coli bacteraemia: an analysis of electronic health records

Yoon CH. et al, (2022)

The quality of vital signs measurements in electronic medical records varies by hospital, specialty, and patient demographics

Jackson N. et al, (2022)

Cookies on this website

Publications